7775 — Daiken Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥16bn
- ¥15bn
- ¥10bn
- 100
- 62
- 76
- 95
Annual cashflow statement for Daiken Medical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,191 | 945 | 1,151 | 1,025 | 1,436 |
| Depreciation | |||||
| Non-Cash Items | 7.09 | 160 | -167 | 46.1 | 29.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.5 | -752 | -165 | -349 | -125 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,437 | 609 | 1,134 | 989 | 1,556 |
| Capital Expenditures | -169 | -312 | -203 | -199 | -169 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 8.4 | 0.141 | 6.98 | -11.5 | 0.036 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -161 | -312 | -196 | -211 | -169 |
| Financing Cash Flow Items | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,128 | -492 | -589 | -781 | -1,164 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 148 | -195 | 348 | -2.38 | 223 |